Officials at the US Food and Drug Administration and European Medicines Agency want to dispel some myths about parallel scientific advice (PSA) to encourage more sponsors to use the program.
The PSA program allows sponsors seeking approval from both regulators to receive scientific opinions from them at the same time, which could help align expectations and avoid unnecessary work. But...